Skip to content

Vitali Azouz, M.D

NPI 1619364783ActiveIndividual· Surgery, Plastic and Reconstructive Surgery· Dallas, TX

Surgery, Plastic and Reconstructive Surgery (M.D) in Dallas, Texas, licensed in TX, with an NPI issued in April 2015. Part D covered 21 prescriptions written in 2024, 81% of them generic. Integra Lifesciences Corporation was the largest of 5 companies reporting payments in 2025, $170.29 in all, mostly food and beverage.

Overview

NPI1619364783
StatusActive
Entity typeIndividual
CredentialM.D
Sole proprietorNo
NPI issuedApr 16, 2015
Last updated in NPPESJun 27, 2023
Certified by providerJun 27, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Surgery, Plastic and Reconstructive Surgery Primary2086S0122XU1231TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)21 · 21 30-day fills
Total drug cost$162.61
Generic share81% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$170.29 · 6 payments from 5 companies
  • 2024$227.48 · 10 payments from 7 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$170.29 · 6 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery, Plastic and Reconstructive Surgery providers in Dallas

All Surgery, Plastic and Reconstructive Surgery providers in Texas →